missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (145 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marca: R&D Systems™ 3718-FB-01M
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Measured in a cell proliferation assay using NR6R-3T3 mouse fibroblast cells. Raines, E.W. et al. (1985) Methods Enzymol. 109:749. The ED50 for this effect is 0.1-0.6 ng/mL.Especificaciones
NP_001997 | |
Lyophilized from a 0.2 μm filtered solution in Tris-HCl and NaCl. | |
M.W. (theoretical): 16 kDa | |
1 mg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
Basic fibroblast growth factor, basic fibroblast growth factor bFGF, bFGF, FGF2, FGF-2, FGFBprostatropin, fibroblast growth factor 2 (basic), HBGF-2, heparin-binding growth factor 2, Prostatropin | |
Unconjugated | |
Reconstitute at 100 μg/mL in sterile PBS. | |
FGF basic/FGF2/bFGF |
Bioactivity | |
2247 | |
FGF basic 145 aa | |
E. coli-derived human FGF basic/FGF2/bFGF protein Ala144-Ser288 | |
<0.01 EU / 1 μg of the protein by the LAL method. | |
FGF2 | |
Recombinant | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido